Evidence map›Paper›PMID 32825680›Full record

ArticleInternational journal of environmental research and public health2020

The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands.

Mohamed N M T Al Khayat, Job F H Eijsink, Maarten J Postma, Jan C Wilschut, Marinus van Hulst

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Modelling the Economic Impact of Reducing Loneliness in Community Dwelling Older People in England.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed N M T Al KhayatDepartment of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands.
Job F H EijsinkDepartment of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands.
Maarten J PostmaDepartment of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands.
Jan C WilschutDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, 9712 CP, Groningen, The Netherlands.
Marinus van HulstDepartment of Health Sciences, University of Groningen, University Medical Center Groningen, 9712 CP Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to assess the cost-effectiveness of hepatitis C virus (HCV) screening strategies among recently arrived migrants in the Netherlands.

methodsA Markov model was used to estimate the health effects and costs of HCV screening from the healthcare perspective. A cohort of 50,000 recently arrived migrants was used. In this cohort, three HCV screening strategies were evaluated: (i) no screening, (ii) screening of migrants from HCV-endemic countries and (iii) screening of all migrants.

resultsStrategy (ii) screening of migrants from HCV-endemic countries compared to strategy (i) no screening, yielded an incremental cost-effectiveness ratio (ICER) of €971 per quality-adjusted life-years (QALYs) gained. Strategy (iii) screening of all migrants compared with strategy (ii) screening of migrants from HCV-endemic countries yielded an ICER of €1005 per QALY gained. The budget impact of strategy (ii) screening of migrants from HCV-endemic countries and strategy (iii) screening of all migrants was €13,752,039 and €20,786,683, respectively.

conclusionHCV screening is cost-effective. However, the budget impact may have a strong influence on decision making.

Indexed as

Hepatitis CMass ScreeningTransients and MigrantsCost-Benefit AnalysisHepacivirusHumansMarkov ChainsNetherlandsQuality-Adjusted Life Yearsbudget impactcost-effectivenesshepatitis Cmigrantsscreening

Identifiers

PMID32825680
PMCPMC7503411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.